| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P819 | ADS bibcode | 2017PLoSO..1271579C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0171579 |
| P932 | PMC publication ID | 5300201 |
| P698 | PubMed publication ID | 28182644 |
| P2093 | author name string | Chien-Yu Lin | |
| Jin-Hua Chen | |||
| Chun-Chih Peng | |||
| Hung-Chih Lin | |||
| Hung-Yang Chang | |||
| Jui-Hsing Chang | |||
| P2860 | cites work | Probiotics for prevention of necrotizing enterocolitis in preterm infants | Q24197461 |
| Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis | Q28081613 | ||
| Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review | Q28263198 | ||
| 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis | Q30860329 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial | Q33440895 | ||
| Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. | Q33463316 | ||
| Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis | Q33496677 | ||
| Carbohydrate maldigestion induces necrotizing enterocolitis in preterm pigs | Q33771713 | ||
| Fecal microbiota in premature infants prior to necrotizing enterocolitis | Q33932986 | ||
| The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants | Q33982024 | ||
| Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging | Q34051652 | ||
| Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome | Q34470700 | ||
| Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial | Q34659239 | ||
| Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. | Q50773084 | ||
| Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model. | Q51821820 | ||
| Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. | Q54420426 | ||
| Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants | Q57570439 | ||
| Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study | Q74593416 | ||
| The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants | Q79577725 | ||
| Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants | Q80877314 | ||
| Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants | Q81224806 | ||
| Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis | Q84068152 | ||
| Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial | Q87422856 | ||
| Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury | Q34746651 | ||
| Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial | Q35110845 | ||
| Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study | Q35220787 | ||
| Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial | Q35285379 | ||
| Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial | Q35738350 | ||
| Gut microbiota and the pathogenesis of necrotizing enterocolitis in preterm neonates | Q35917256 | ||
| Epidemiology of necrotizing enterocolitis--Part I: Changing regional trends in extremely preterm infants over 14 years | Q36090759 | ||
| Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials | Q36820897 | ||
| Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies | Q36840426 | ||
| Probiotics for necrotizing enterocolitis: a systematic review | Q37009757 | ||
| A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids | Q37345483 | ||
| Role of Enteric Supplementation of Probiotics on Late-onset Sepsis by Candida species in Preterm Low Birth Weight Neonates: A Randomized, Double Blind, Placebo-controlled Trial. | Q37610552 | ||
| Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates | Q37733964 | ||
| Health benefits of probiotics: are mixtures more effective than single strains? | Q37828084 | ||
| Pathogenesis implication for necrotizing enterocolitis prevention in preterm very-low-birth-weight infants | Q38174752 | ||
| Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study | Q39927380 | ||
| Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial | Q40886498 | ||
| Probiotic administration can prevent necrotizing enterocolitis in preterm infants: A meta-analysis | Q41542069 | ||
| Enteral feeding of premature infants with Lactobacillus GG | Q41817204 | ||
| Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial | Q42240129 | ||
| The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. | Q43360746 | ||
| Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial | Q43931369 | ||
| Enteral feeding of premature infants with Saccharomyces boulardii | Q44633338 | ||
| Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial | Q44633691 | ||
| Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study | Q46087545 | ||
| The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. | Q46313765 | ||
| Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. | Q46541149 | ||
| Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates | Q47172563 | ||
| Mortality of necrotizing enterocolitis expressed by birth weight categories | Q47180258 | ||
| Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial | Q47187980 | ||
| Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. | Q47212470 | ||
| Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials | Q47332291 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates | Q47370646 | ||
| Probiotics-supplemented feeding in extremely low-birth-weight infants | Q47377896 | ||
| Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis | Q47390151 | ||
| Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial | Q47395591 | ||
| Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial | Q47407913 | ||
| Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial | Q47440727 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| probiotics | Q1816730 | ||
| necrotizing enterocolitis | Q10859678 | ||
| P304 | page(s) | e0171579 | |
| P577 | publication date | 2017-02-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis | |
| P478 | volume | 12 |
| Q92459827 | Bacteroides fragilis Strain ZY-312 Defense against Cronobacter sakazakii-Induced Necrotizing Enterocolitis In Vitro and in a Neonatal Rat Model |
| Q92723253 | Dysbiosis and Prematurity: Is There a Role for Probiotics? |
| Q89027309 | Effect of direct-fed microbials on culturable gut microbiotas in broiler chickens: a meta-analysis of controlled trials |
| Q88348159 | Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study |
| Q92210703 | Exploring the Science behind Bifidobacterium breve M-16V in Infant Health |
| Q57478925 | Filling the Gaps: Current Research Directions for a Rational Use of Probiotics in Preterm Infants |
| Q98778636 | Grading the evidence to identify strategies to modify risk for necrotizing enterocolitis |
| Q59340698 | Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial |
| Q58714655 | Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome |
| Q37729862 | Hypocholesterolemic Effects of Probiotic Mixture on Diet-Induced Hypercholesterolemic Rats |
| Q57175340 | Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
| Q55424259 | Lactobacillus murinus HF12 colonizes neonatal gut and protects rats from necrotizing enterocolitis. |
| Q90908555 | Nutritional interventions to reduce rates of infection, necrotizing enterocolitis and mortality in very preterm infants |
| Q64065562 | Prevention of necrotizing enterocolitis in premature infants - an updated review |
| Q47128430 | Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials. |
| Q47252497 | Probiotics and necrotizing enterocolitis |
| Q41435416 | Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q57812807 | Probiotics in Autoimmune and Inflammatory Disorders |
| Q57141422 | Probiotics in Disease Prevention and Treatment |
| Q61809045 | Recent advances in understanding necrotizing enterocolitis |
| Q98778637 | Safety and efficacy of probiotic administration to preterm infants: ten common questions |
| Q89548454 | Synbiotic use for the prevention of sepsis and necrotizing enterocolitis in very low birth weight neonates: a randomized controlled trial |
| Q89627106 | The Gut Microbiome Distinguishes Mortality in Trauma Patients Upon Admission to the Emergency Department |
| Q47118988 | They Are What You Eat: Can Nutritional Factors during Gestation and Early Infancy Modulate the Neonatal Immune Response? |
Search more.